Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its Improvement.
Economic burden of multiple sclerosis and the role of managed sare organizations in multiple sclerosis management.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No.
Occupational mercury exposure in association with prevalence of multiple sclerosis and tremor among US dentists.
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
Individuals with multiple sclerosis redistribute positive mechanical work from the ankle to the hip during walking.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
Conformational changes associated with L16P and T118M mutations in the membrane embedded PMP22 protein, consequential in CMT-1A.
A multiple sclerosis-like disorder in patients with OPA1 mutations.
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals.
Immunotherapy-responsive Allodynia due to Distal Acquired Demyelinating Symmetric (DADS) Neuropathy.
Acute idiopathic polyradiculoneuritis concurrent with acquired myasthenia gravis in a West Highland white terrier dog.
Inhibitors of urokinase type plasminogen activator and cytostatic activity from crude plants extracts.
Products
Orthopaedic manifestations and diagnostic clues in children with Guillain-Barré syndrome.
Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.
Should we care about sativex-induced neurobehavioral effects? A 6-month follow-up study.
Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?
Corrigendum.
Thrombin and Protein C Pathway in Peripheral Nerve Schwann Cells.
Ectopic Lymphoid Structures: Powerhouse of Autoimmunity.
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.

Pages